摘要：
Objective To analyze the influencing factors of innovation in biomedical enterprises from the perspective of
technological resources and to provide reference for the layout of technological resources and the strategic
innovation development of biomedical enterprises. Methods 243 biomedical enterprises were analyzed using
econometric models for the influencing factors of innovation performance. Results and Conclusion The use
of both general-purpose technologies (GPTs) and key enabling technologies (KETs) in biomedical enterprises
significantly improves enterprise innovation performance. Besides, the level of technological diversification of
an enterprise partially mediates the relationship between GPTs and innovation performance, and the level of
technological specialization of an enterprise partially mediates the relationship between KETs and innovation
performance. Lastly, firm’s absorptive capacity positively moderates the relationship between GPTs and firms’
technological diversification and the relationship between KETs and technological specialization.
Zhang Yimeng, Liu Xinrui, Tian Huijing, Yuan Hongmei. Research on the Impact of General Purpose Technologies and Key
Enabling Technologies on Innovation in Biomedical Enterprises[J]. 亚洲社会药学, 2026, 21(2): 174-189.
Zhang Yimeng, Liu Xinrui, Tian Huijing, Yuan Hongmei. Research on the Impact of General Purpose Technologies and Key
Enabling Technologies on Innovation in Biomedical Enterprises[J]. Asian Journal of Social Pharmacy, 2026, 21(2): 174-189.
